Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
30 Cards in this Set
- Front
- Back
Hydrolyzed ASA (salicylate) reversibly inhibits:
|
Prostaglandin synthesis
|
|
ASA: if you saturate all the plasma proteins, then you have an increased half life d/t a :
|
Huge reservoir
|
|
30% of ASA is excreted in ______ urine
|
Alkaline
|
|
2% of ASA is excreted in _____ urine
|
Acidic
|
|
Competitive inhibitor of COX
|
Diflunisal
|
|
More potent anti-inflammatory agent than ASA but no anti-pyretic effect (poor CNS penetration)
|
Diflunisal
|
|
Used for sprains, OA, rheumatoid arthritis. Less GI upset and anti-platelet effects than ASA
|
Diflunisal
|
|
Anti-microbial used for UC and regional enteritis. Is a type of salicylate
|
Sulfasalazine
|
|
Sulfasalazine is _______ in the GI tract and that's why it is good for treating UC
|
Poorly absorbed
|
|
Sulfasalazine may have a high risk for:
|
Hepatic damage
|
|
Metabolite of sulfasalazine
|
Olsalazine
|
|
Gastric ulceration and bleeding s/e of salicylic acid I is a ________ phenomenon
|
Dose dependent
|
|
GI bleeding may be only partially mediated by:
|
COX1 inhibition
|
|
Responsible for increasing the level of gastric mucosal secretions which is protective against acids
|
COX1
|
|
Has a cross sensitivity to other NSAIDS such as indomethacin
|
ASA
|
|
High doses of ASA can result in:
|
CNS-salicylism
|
|
Salicylates can cause early respiratory _________ d/t _____ (in adults)
|
Alkalosis, hyperventilation
|
|
Salicylates can cause late respiratory and metabolic _______ (in adults)
|
Acidosis
|
|
Salicylates in infants cause:
|
Resp and metabolic acidosis
|
|
Use of nonselective NSAIDs is associated with a significantly increased risk of:
|
Gastric and duodenal ulcers
|
|
Majority of pts hospitalized for NSAID-induced ulcer complications have:
|
No warning symptoms
|
|
NSAID use if associated with significant ______ although the statistics are disputed
|
Morbidity and mortality
|
|
Relative risk of NSAID induced UGI toxicity does ______ with long term therapy
|
Not decline
|
|
Can be used for prevention of GI toxicity with NSAID use
|
Misoprostol, proton pump inhibitors, H-2 receptor antagonist
|
|
Synthetic analog of prostaglandin E1 used to decrease GI inflammation with salicylates or NSAIDS
|
Misoprostol
|
|
Misoprostol is expensive and s/e include:
|
N and severe diarrhea
|
|
Misoprostol can cause:
|
Abortion, premature birth, birth defects
|
|
Block gastric acid production:
|
Proton pump inhibitors
|
|
Example of proton pump inhibitor
|
Omeprazole, esomeprazole
|
|
Example of H-2 receptor antagonist:
|
Famotidine
|